Beyond Data: Understanding the “Why” Behind HCP Decisions

AI is transforming healthcare by making guidelines, clinical trial data and emerging research more accessible than ever. But according to Alexandra Laymon, Chief Sales Officer at Healthcasts, access to information is only the beginning. As healthcare professionals navigate an increasingly complex landscape, the real value comes from validating insights through peer-to-peer conversations, trusted colleagues and expert networks.

In this interview, Laymon explains why healthcare professionals often seek discussion and confirmation before making treatment decisions, and how those interactions create opportunities for deeper understanding. While traditional data sources can show what physicians prescribe, they often fail to explain why those decisions are made. That missing context can be critical for uncovering changing preferences, treatment considerations, and evolving brand sentiment.

The conversation also explores how marketers can move beyond awareness metrics such as reach and impressions to better understand the behaviors and conversations that influence clinical decision making. Drawing on insights from Healthcasts, Laymon examines how a deeper understanding of these factors can help marketers drive more meaningful engagement and measurable impact. Watch the full interview to hear her perspective.

The editorial staff had no role in this post's creation.